MXPA03002326A - Compuestos heterociclicos de union de receptor de quimocina. - Google Patents
Compuestos heterociclicos de union de receptor de quimocina.Info
- Publication number
- MXPA03002326A MXPA03002326A MXPA03002326A MXPA03002326A MXPA03002326A MX PA03002326 A MXPA03002326 A MX PA03002326A MX PA03002326 A MXPA03002326 A MX PA03002326A MX PA03002326 A MXPA03002326 A MX PA03002326A MX PA03002326 A MXPA03002326 A MX PA03002326A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor binding
- heterocyclic compounds
- chemokine receptor
- binding heterocyclic
- ccr5
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23289100P | 2000-09-15 | 2000-09-15 | |
US23451000P | 2000-09-22 | 2000-09-22 | |
PCT/CA2001/001326 WO2002022600A2 (en) | 2000-09-15 | 2001-09-17 | Chemokine receptor binding heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03002326A true MXPA03002326A (es) | 2003-06-06 |
Family
ID=26926422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03002326A MXPA03002326A (es) | 2000-09-15 | 2001-09-17 | Compuestos heterociclicos de union de receptor de quimocina. |
Country Status (22)
Country | Link |
---|---|
US (3) | US6864265B2 (es) |
EP (1) | EP1317445B1 (es) |
JP (1) | JP2004508422A (es) |
KR (1) | KR20030029998A (es) |
CN (1) | CN1457339A (es) |
AT (1) | ATE425157T1 (es) |
AU (2) | AU9156901A (es) |
BR (1) | BR0113930A (es) |
CA (1) | CA2419224A1 (es) |
DE (1) | DE60137944D1 (es) |
ES (1) | ES2325909T3 (es) |
HK (1) | HK1052011A1 (es) |
HU (1) | HUP0301093A2 (es) |
IL (1) | IL154227A0 (es) |
MX (1) | MXPA03002326A (es) |
NO (1) | NO20031179L (es) |
NZ (1) | NZ524420A (es) |
PL (1) | PL360932A1 (es) |
RU (1) | RU2289581C2 (es) |
SG (1) | SG126007A1 (es) |
TR (1) | TR200300322T2 (es) |
WO (1) | WO2002022600A2 (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9156901A (en) * | 2000-09-15 | 2002-03-26 | Anormed Inc | Chemokine receptor binding heterocyclic compounds |
US6734191B2 (en) | 2000-09-15 | 2004-05-11 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
WO2002022599A2 (en) * | 2000-09-15 | 2002-03-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
US7169750B2 (en) | 2001-07-31 | 2007-01-30 | Anormed, Inc. | Methods to mobilize progenitor/stem cells |
MXPA04000982A (es) | 2001-07-31 | 2004-04-20 | Anormed Inc | Metodos para movilizar celulas progenitoras/madre. |
US7354932B2 (en) * | 2001-12-21 | 2008-04-08 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
MXPA04006136A (es) * | 2001-12-21 | 2004-11-01 | Anormed Inc | Compuestos heterociclicos que se unen a receptor de quimiocina con eficacia incrementada. |
US7176227B2 (en) | 2002-09-11 | 2007-02-13 | Kureha Corporation | Amine compounds and use thereof |
US7399776B2 (en) | 2003-04-02 | 2008-07-15 | Taigen Biotechnology | Polyamine compounds for treating chemokine receptor mediated diseases |
US7504422B2 (en) | 2003-04-02 | 2009-03-17 | Taigen Biotechnology Co. Ltd. | Polyamine compounds |
WO2004091518A2 (en) | 2003-04-11 | 2004-10-28 | Anormed Inc. | Cxcr4 chemokine receptor binding compounds |
US7498323B2 (en) * | 2003-04-18 | 2009-03-03 | Ono Pharmaceuticals Co., Ltd. | Spiro-piperidine compounds and medicinal use thereof |
US7550484B2 (en) | 2003-04-22 | 2009-06-23 | Genzyme Corporation | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
US7501518B2 (en) | 2003-04-22 | 2009-03-10 | Genzyme Corporation | Methods of making 2,6-diaryl piperidine derivatives |
CN1829709A (zh) * | 2003-08-01 | 2006-09-06 | 健亚生物科技公司 | 对抗黄病毒的双环咪唑衍生物 |
EP1708703A4 (en) | 2003-12-11 | 2008-04-09 | Anormed Inc | CHEMOKIN RECEPTOR BINDING COMPOUNDS |
US7498346B2 (en) | 2003-12-11 | 2009-03-03 | Genzyme Corporation | Chemokine receptor binding compounds |
CN1950343B (zh) * | 2004-03-10 | 2013-06-19 | 株式会社吴羽 | 胺系碱性化合物及其用途 |
CA2558389C (en) * | 2004-03-15 | 2013-10-08 | Anormed, Inc. | Process for the synthesis of a cxcr4 antagonist |
EP1732905A1 (en) * | 2004-03-31 | 2006-12-20 | Lexicon Genetics Incorporated | 2-aminomethylthiazole-5-carboxamides as protein kinase modulators |
JP2008509928A (ja) * | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆/幹細胞を動員するためのケモカインの組み合わせ |
CA2577100A1 (en) * | 2004-08-16 | 2006-03-02 | Smithkline Beecham Corporation | Chemical compounds |
BRPI0514487A (pt) * | 2004-08-19 | 2008-06-17 | Colgate Palmolive Co | método de preparar uma composição, e, composição |
US7951816B2 (en) * | 2004-08-27 | 2011-05-31 | Ono Pharmaceutical Co., Ltd. | Compound containing basic group and use thereof |
WO2006026703A2 (en) * | 2004-09-02 | 2006-03-09 | Smithkline Beecham Corporation | Chemical compounds |
EP1793825A4 (en) * | 2004-09-24 | 2009-12-09 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
TW200619206A (en) * | 2004-09-29 | 2006-06-16 | Anormed Inc | Chemokine-binding heterocyclic compound salts, and methods of use thereof |
WO2006076529A1 (en) * | 2005-01-14 | 2006-07-20 | Genelabs Technologies, Inc. | Indole derivatives for treating viral infections |
US7501526B2 (en) | 2005-01-20 | 2009-03-10 | Taigen Biotechnology | Synthesis of polyamine compounds |
EP1942890A4 (en) | 2005-06-15 | 2009-08-26 | Genzyme Corp | CHEMOKINE RECEPTOR BINDING COMPOUNDS |
JP2009500451A (ja) * | 2005-07-11 | 2009-01-08 | スミスクライン ビーチャム コーポレーション | ピラノピリジン化合物 |
BRPI0615180A2 (pt) | 2005-08-19 | 2011-05-03 | Genzyme Corp | método para intensificar a quimioterapia |
ES2407115T3 (es) * | 2005-11-18 | 2013-06-11 | Ono Pharmaceutical Co., Ltd. | Compuesto que contiene un grupo básico y uso del mismo |
US7807704B2 (en) * | 2006-03-30 | 2010-10-05 | Chemocentryx, Inc. | Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 |
US7671069B2 (en) | 2006-03-30 | 2010-03-02 | Chemocentryx, Inc. | Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7 |
JP5257068B2 (ja) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | 保護されていてもよい酸性基を含有する化合物およびその用途 |
CN101495115A (zh) * | 2006-08-02 | 2009-07-29 | 健赞股份有限公司 | 组合治疗 |
JP2010507567A (ja) * | 2006-08-07 | 2010-03-11 | ジェンザイム・コーポレーション | 併用療法 |
WO2009036341A2 (en) * | 2007-09-14 | 2009-03-19 | The Regents Of The University Of Michigan | Compositions and methods relating to hiv protease inhibition |
PE20110164A1 (es) * | 2008-07-02 | 2011-03-28 | Hoffmann La Roche | Nuevas fenilpirazinonas como inhibidores de quinasa |
JP2012502048A (ja) * | 2008-09-08 | 2012-01-26 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法 |
EP2646430B1 (en) | 2010-12-03 | 2016-09-21 | Emory University | Chemokine cxcr4 receptor modulators and uses related thereto |
CN102603683B (zh) * | 2012-02-10 | 2014-04-09 | 山东大学 | 一种呋喃类化合物及其制备方法与应用 |
CN104478795A (zh) * | 2014-11-24 | 2015-04-01 | 苏州乔纳森新材料科技有限公司 | 一种2-氯烟醛的制备方法 |
CA3026154A1 (en) | 2015-06-03 | 2016-12-08 | The University Of Queensland | Mobilizing agents and uses therefor |
CN104945313A (zh) * | 2015-06-19 | 2015-09-30 | 洪帅金 | 一种2-甲基-3-溴吡啶的制备方法 |
BR112018007021B1 (pt) * | 2015-10-06 | 2024-01-09 | Proteostasis Therapeutics, Inc | Composto, composição compreendendo os ditos compostos e uso dos mesmos para tratar fibrose cística |
CN105198802A (zh) * | 2015-11-03 | 2015-12-30 | 江苏梦得电镀化学品有限公司 | 一种2-甲基-3-溴吡啶的制备方法 |
EP3389634B1 (en) | 2015-12-14 | 2021-10-06 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
CN109069486A (zh) | 2015-12-14 | 2018-12-21 | X4 制药有限公司 | 治疗癌症的方法 |
SI3393468T1 (sl) | 2015-12-22 | 2023-01-31 | X4 Pharmaceuticals, Inc. | Postopki za zdravljenje bolezni imunske pomanjkljivosti |
JP2019510785A (ja) | 2016-04-08 | 2019-04-18 | エックス4 ファーマシューティカルズ, インコーポレイテッド | 癌を処置する方法 |
EP3471726A4 (en) | 2016-06-21 | 2019-10-09 | X4 Pharmaceuticals, Inc. | CXCR4 INHIBITORS AND USES THEREOF |
WO2017223243A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
US10759796B2 (en) | 2016-06-21 | 2020-09-01 | X4 Pharmaceuticals, Inc. | CXCR4 inhibitors and uses thereof |
WO2018073248A1 (en) | 2016-10-17 | 2018-04-26 | Icm (Institut Du Cerveau Et De La Moelle Épinière) | Prognosis of demyelinating diseases patients and treatment thereof |
US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
GB201910608D0 (en) * | 2019-07-24 | 2019-09-04 | Enterprise Therapeutics Ltd | Compounds |
CN112110853A (zh) * | 2020-09-23 | 2020-12-22 | 海南梵圣生物科技有限公司 | 一种合成3-羟基-2-吡啶甲酸及其衍生物的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021409A (en) | 1989-12-21 | 1991-06-04 | Johnson Matthey Plc | Antiviral cyclic polyamines |
US6001826A (en) * | 1989-12-21 | 1999-12-14 | Anormed, Inc. | Chemical compounds |
GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
GB9400411D0 (en) | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
GB9511357D0 (en) * | 1995-06-06 | 1995-08-02 | Johnson Matthey Plc | Improved antiviral compounds |
BR9810600A (pt) | 1997-07-16 | 2000-07-11 | Ciba Sc Holding Ag | Compostos espiro-poliglicidila e seu uso em resinas epóxi |
JP2002501898A (ja) * | 1998-02-02 | 2002-01-22 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性の環状アミン調節剤 |
JPH11269146A (ja) * | 1998-03-24 | 1999-10-05 | Mitsui Chem Inc | 分化誘導剤 |
JP2002535256A (ja) * | 1999-01-25 | 2002-10-22 | スミスクライン・ビーチャム・コーポレイション | 化合物および方法 |
US6362201B1 (en) * | 1999-03-02 | 2002-03-26 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
EP1163238B1 (en) * | 1999-03-24 | 2006-05-31 | Anormed Inc. | Chemokine recpetor binding heterocyclic compounds |
US6750348B1 (en) * | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
WO2002022599A2 (en) * | 2000-09-15 | 2002-03-21 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
AU9156901A (en) * | 2000-09-15 | 2002-03-26 | Anormed Inc | Chemokine receptor binding heterocyclic compounds |
-
2001
- 2001-09-17 AU AU9156901A patent/AU9156901A/xx active Pending
- 2001-09-17 AU AU2001291569A patent/AU2001291569B2/en not_active Ceased
- 2001-09-17 DE DE60137944T patent/DE60137944D1/de not_active Expired - Lifetime
- 2001-09-17 MX MXPA03002326A patent/MXPA03002326A/es active IP Right Grant
- 2001-09-17 EP EP01971574A patent/EP1317445B1/en not_active Expired - Lifetime
- 2001-09-17 CN CN01815627A patent/CN1457339A/zh active Pending
- 2001-09-17 US US09/957,682 patent/US6864265B2/en not_active Expired - Fee Related
- 2001-09-17 HU HU0301093A patent/HUP0301093A2/hu unknown
- 2001-09-17 SG SG200502184A patent/SG126007A1/en unknown
- 2001-09-17 BR BR0113930-4A patent/BR0113930A/pt not_active IP Right Cessation
- 2001-09-17 IL IL15422701A patent/IL154227A0/xx unknown
- 2001-09-17 TR TR2003/00322T patent/TR200300322T2/xx unknown
- 2001-09-17 ES ES01971574T patent/ES2325909T3/es not_active Expired - Lifetime
- 2001-09-17 CA CA002419224A patent/CA2419224A1/en not_active Abandoned
- 2001-09-17 AT AT01971574T patent/ATE425157T1/de not_active IP Right Cessation
- 2001-09-17 NZ NZ524420A patent/NZ524420A/en unknown
- 2001-09-17 RU RU2003110577/04A patent/RU2289581C2/ru not_active IP Right Cessation
- 2001-09-17 KR KR10-2003-7003710A patent/KR20030029998A/ko active IP Right Grant
- 2001-09-17 JP JP2002526853A patent/JP2004508422A/ja active Pending
- 2001-09-17 PL PL36093201A patent/PL360932A1/xx unknown
- 2001-09-17 WO PCT/CA2001/001326 patent/WO2002022600A2/en active IP Right Grant
-
2003
- 2003-03-14 NO NO20031179A patent/NO20031179L/no not_active Application Discontinuation
- 2003-06-18 HK HK03104377.2A patent/HK1052011A1/zh unknown
-
2004
- 2004-06-01 US US10/858,910 patent/US7084155B2/en not_active Expired - Fee Related
-
2006
- 2006-02-02 US US11/345,987 patent/US7396840B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2419224A1 (en) | 2002-03-21 |
NO20031179D0 (no) | 2003-03-14 |
IL154227A0 (en) | 2003-07-31 |
HUP0301093A2 (hu) | 2003-09-29 |
EP1317445B1 (en) | 2009-03-11 |
BR0113930A (pt) | 2003-06-24 |
PL360932A1 (en) | 2004-09-20 |
WO2002022600A3 (en) | 2002-05-10 |
KR20030029998A (ko) | 2003-04-16 |
TR200300322T2 (tr) | 2003-09-22 |
US20030018046A1 (en) | 2003-01-23 |
NZ524420A (en) | 2005-04-29 |
EP1317445A2 (en) | 2003-06-11 |
CN1457339A (zh) | 2003-11-19 |
US7396840B2 (en) | 2008-07-08 |
WO2002022600A2 (en) | 2002-03-21 |
NO20031179L (no) | 2003-03-14 |
ATE425157T1 (de) | 2009-03-15 |
HK1052011A1 (zh) | 2003-08-29 |
ES2325909T3 (es) | 2009-09-24 |
RU2289581C2 (ru) | 2006-12-20 |
US7084155B2 (en) | 2006-08-01 |
AU2001291569B2 (en) | 2007-07-26 |
SG126007A1 (en) | 2006-10-30 |
JP2004508422A (ja) | 2004-03-18 |
US20040220207A1 (en) | 2004-11-04 |
US6864265B2 (en) | 2005-03-08 |
US20060128750A1 (en) | 2006-06-15 |
AU9156901A (en) | 2002-03-26 |
DE60137944D1 (de) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154227A0 (en) | Chemokine receptor binding heterocyclic compounds | |
WO2002034745A8 (en) | Chemokine receptor binding heterocyclic compounds | |
TR200102029T2 (tr) | 1-Heterosiklil ikameli diarilaminler. | |
HUP0200761A3 (en) | Chemokine receptor binding heterocyclic compounds, pharmaceutical compositions containing them and their use | |
MY143366A (en) | Muscarinic acetylcholine receptor antagonists | |
HK1046905A1 (en) | Cyclic amine compound as ccr5 antagonist | |
GB0115862D0 (en) | Compounds | |
HK1039330A1 (en) | Piperidine derivatives useful as ccr5 antagonists. | |
UY27927A1 (es) | Antagonistas del receptor muscarínico m3 de acetilcolina | |
EP1117692A4 (en) | ANTIBODIES AGAINST TIE2 ANTAGONISTS | |
DE69837606D1 (de) | Cystein-reiche rezeptoren-train | |
ECSP066486A (es) | Antagonistas de receptores de acetilcolina muscarínicos ii | |
EP1244452A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
MXPA06000662A (es) | Antagonistas del receptor muscarinico de acetilcolina. | |
MXPA06000664A (es) | Antagonistas del receptor muscarinico de acetilcolina. | |
AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
MXPA06000663A (es) | Antagonistas del receptor muscarinico de acetilcolina. | |
BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
AU2003267088A8 (en) | Chemokine receptor antagonists as therapeutic agents | |
EP1248607A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
HK1046414A1 (zh) | 趨化因子受體ccr3拮抗劑 | |
EP1246619A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
WO2002057313A8 (en) | Receptor-binding compounds and methods for identifying them | |
WO2001071346A3 (en) | Binding compounds for cc chemokine receptor 5 and methods for identifying them | |
ZA200301399B (en) | Chemokine receptor binding heterocyclic compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |